Tanox not only successfully developed a new anti-allergy drug, it is now completing the Phase II clinical trial for another drug, Anti-CD4, used for late-stage AIDS patients for whom drug cocktail treatments no longer work. And it appears that success is just around the corner.
張子文夫妻創立的 Tanox 公司，不僅成功研發了抗過敏新藥，另一種用來治療雞尾酒療法失效的晚期愛滋病人藥物（Anti ─ CD4），目前也已完成第二期臨床試驗，眼看著成功也唾手可得。